Press Releases InMed Receives over $1,350,000 From Warrant Exercise February 27, 2017 Read More » InMed Pharmaceuticals to Present at the 2017 BIO CEO & Investor Conference February 9, 2017 Read More » InMed Pharmaceuticals, Inc. Closes Non-Brokered Private Placement for C$1,500,000 January 18, 2017 Read More » InMed Pharmaceuticals Appoints Martin Bott to Board of Directors January 13, 2017 Read More » InMed Pharmaceuticals, Inc. Announces Non-Brokered Private Placement of C$1,000,000 January 9, 2017 Read More » InMed Launches New Website January 9, 2017 Read More » InMed Provides 2016 Year End Update December 23, 2016 Read More » InMed Pharmaceuticals Announces Appointment of Veteran Biotech CFO, Jeff Charpentier December 15, 2016 Read More » InMed announces progress on COPD program December 6, 2016 Read More » InMed to Present at Cannabis-Based Therapies Conference November 23, 2016 Read More » InMed Pharmaceuticals, Inc. Appoints Senior Vice President, Clinical and Regulatory Affairs October 31, 2016 Read More » InMed Pharmaceuticals, Inc. Closes Non-Brokered Private Placement for C$1,500,000 October 27, 2016 Read More » InMed Pharmaceuticals, Inc. Announces Non-Brokered Private Placement of C$1,500,000 October 4, 2016 Read More » InMed Appoints Andrew Hull to the Board of Directors September 13, 2016 Read More » InMed to Present at 18th Annual Rodman and Renshaw Global Investment Conference September 12, 2016 Read More » InMed Pharmaceuticals, Inc. Closes Non-Brokered Private Placement for C$304,500 July 28, 2016 Read More » InMed Pharmaceuticals, Inc. Announces Non-Brokered Private Placement of C$250,000 July 19, 2016 Read More » InMed Announces Appointment of Eric A. Adams as CEO, President and Director June 16, 2016 Read More » InMed Announces Appointment of William J. Garner, M.D. to its Board of Directors June 13, 2016 Read More » InMed Updates Progress of its Epidermolysis Bullosa Program May 18, 2016 Read More » « Previous Page1 Page2 Page3 Page4 Page5 Page6 Page7 Page8 Page9 Page10 Page11 Page12 Page13 Next » Management Learn More Board of Directors Learn More Scientific Advisory Board Learn More Investor Alerts Sign up to receive news releases from InMed Pharmaceuticals. SIGN UP
InMed Pharmaceuticals to Present at the 2017 BIO CEO & Investor Conference February 9, 2017 Read More »
InMed Pharmaceuticals, Inc. Closes Non-Brokered Private Placement for C$1,500,000 January 18, 2017 Read More »
InMed Pharmaceuticals, Inc. Announces Non-Brokered Private Placement of C$1,000,000 January 9, 2017 Read More »
InMed Pharmaceuticals Announces Appointment of Veteran Biotech CFO, Jeff Charpentier December 15, 2016 Read More »
InMed Pharmaceuticals, Inc. Appoints Senior Vice President, Clinical and Regulatory Affairs October 31, 2016 Read More »
InMed Pharmaceuticals, Inc. Closes Non-Brokered Private Placement for C$1,500,000 October 27, 2016 Read More »
InMed Pharmaceuticals, Inc. Announces Non-Brokered Private Placement of C$1,500,000 October 4, 2016 Read More »
InMed to Present at 18th Annual Rodman and Renshaw Global Investment Conference September 12, 2016 Read More »
InMed Pharmaceuticals, Inc. Closes Non-Brokered Private Placement for C$304,500 July 28, 2016 Read More »
InMed Pharmaceuticals, Inc. Announces Non-Brokered Private Placement of C$250,000 July 19, 2016 Read More »
InMed Announces Appointment of Eric A. Adams as CEO, President and Director June 16, 2016 Read More »
InMed Announces Appointment of William J. Garner, M.D. to its Board of Directors June 13, 2016 Read More »